Trials / Unknown
UnknownNCT05365191
A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients
Development and Utilization of Indocyanine Green Fluorescence Near Infrared Zone II Lymphography in Breast Cancer Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- National Taiwan University Hospital Hsin-Chu Branch · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study aims for evaluating near infrared zone II imaging in sentinel lymph node mapping in breast cancer patients.
Detailed description
Multi-wavelength fluorescence has been surveyed in various fields of surgery. However, it was still under investigation, and has not been matured for clinical use. This study will evaluate near infrared zone II spectrums for breast cancer patient undergoing sentinel lymph node mapping with near-infrared fluorescence navigation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Near infrared fluorescence navigated sentinel lymph node mapping | Participants undergo sentinel lymph node biopsy for breast cancer, and use blue dye/Tc99m radioisotope as primary tracer. Indocyanine green near infrared fluorescence as secondary tracer for mapping. |
Timeline
- Start date
- 2022-04-08
- Primary completion
- 2023-04-07
- Completion
- 2023-04-07
- First posted
- 2022-05-09
- Last updated
- 2022-05-09
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05365191. Inclusion in this directory is not an endorsement.